RAPIDPOINT 405 NEONATAL BILIRUBIN
K-Number: K110277 · 2011-08-15
Advertisement
Device Summary
Frequently Asked Questions
What is the RAPIDPOINT 405 NEONATAL BILIRUBIN?
RAPIDPOINT 405 NEONATAL BILIRUBIN is a medical device that received FDA 510(k) clearance on 2011-08-15. The listed applicant is Siemens Healthcare Diagnostics. The 510(k) number is K110277.
When did RAPIDPOINT 405 NEONATAL BILIRUBIN receive FDA 510(k) clearance?
RAPIDPOINT 405 NEONATAL BILIRUBIN received FDA 510(k) clearance on 2011-08-15, under 510(k) number K110277.
Who is the listed applicant for RAPIDPOINT 405 NEONATAL BILIRUBIN?
The FDA 510(k) record lists Siemens Healthcare Diagnostics as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for RAPIDPOINT 405 NEONATAL BILIRUBIN?
The FDA product code for RAPIDPOINT 405 NEONATAL BILIRUBIN is MQM.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Siemens Healthcare Diagnostics as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: MQM)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement